Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

The Interaction of Social Factors With Air Pollution (SOZIAL)

25 de julio de 2017 actualizado por: David Diaz-Sanchez, Environmental Protection Agency (EPA)

Purpose:

The purpose of this protocol is to understand how social factors such as psychosocial stress may modify how people respond to air pollution. Ultimately this will help us understand health disparities from poor air quality.

Participants:

Up to 40 healthy adults,18-33 years old with different perception of stress will participate and complete this study.

Procedures (methods):

Subjects will be exposed to clean air and to ozone ( 300ppb) for 2 hours in a controlled environment chamber. Cardiac, vascular, pulmonary and cognitive function will be evaluated pre, immediately post and 18 hr post exposure.

The primary endpoint will be Heart Rate Variability . Secondary endpoints will include pulmonary function, analysis of blood clotting/coagulation factors, biomarkers of stress, cognitive function, radial artery pulse wave measurements and analysis of soluble factors present in plasma.

Descripción general del estudio

Descripción detallada

Over the past decades, air quality in the U.S. has improved significantly. Even so, millions of people in the U.S. still live in counties that do not meet air quality standards for one or more pollutants. Ozone is a major component of photochemical smog and is one of the most thoroughly studied gaseous pollutants. Controlled human exposure studies have been critical in demonstrating that it can cause airway inflammation 1-3, including increases in neutrophil infiltration into the lung and the production of pro-inflammatory mediators 4,5[, and ultimately decrements in lung function [reviewed in 6]. More recent studies have shown that ozone can also increase vascular inflammation, as well as alter autonomic nervous system control of heart rate and cardiac repolarization 7. Numerous epidemiological studies have also demonstrated an association between acute and chronic exposure to ambient levels of ozone and various health effects most notably asthma 6. These studies have also highlighted a need to incorporate social and nonchemical factors into risk assessments 8. Similarly, social factors such as psychological stress are now regarded as important contributors to asthma outcomes 9,10. This protocol is aimed at investigating how stress impacts health responses to air pollutants. Since psychosocial stress-related susceptibility has been proposed to explain social disparities, this will help us understand which populations and individuals are at increased risk from air pollution.

This protocol is designed to determine whether nonchemical stressors exacerbate ozone effects. In particular we will focus on elevated psychosocial stress as it has been shown to contribute to several adverse health outcomes, most notably, to cardiovascular disease. The physiological mechanism by which psychosocial stress leads to health effects is due, at least in part, to elevated circulating glucocorticoids, or stress hormones, which are regulated by the hypothalamic-pituitary-adrenal (HPA). In the last 30 years the concept of allostasis has evolved. Allostasis is the process whereby an organism adapts to the demands of the environment. An allostatic load model applies this concept to chronic stress11. In this model the perception of threat over long time intervals (perceived stress) can cause over-activation of the HPA-axis resulting in changes in physiological systems as chemical imbalances in autonomic nervous system, central nervous system, neuroendocrine, and immune system activity. Factors such as genetics, behavior, life events and diet can impact this model. To our knowledge no clinical study has investigated the link between air pollution effects on cardiovascular disease and psychosocial stress. However, several studies have now shown an association between stress and respiratory outcomes to air pollution. Claugherty and colleagues (2007) found an association between traffic-related air pollution and asthma solely among children exposed to violence 12. Shankardass and colleagues demonstrated that children from stressful households are more susceptible to the effects of traffic-related pollution on the development of asthma 13. In that study, stress was evaluated using the Perceived Stress Scale (PSS) developed by Dr. Sheldon Cohen of Carnegie Mellon University. This is the most widely used psychological instrument for measuring the perception of stress and has been validated in multiple studies. We will use this scale to evaluate the degree to which subjects appraise situations in their life as stressful. Heart rate variability (HRV) is considered to be a reliable biomarker of stress. Chronic stress has been shown to be associated with decreases in HRV 14. Since acute ozone exposure can also cause changes in HRV, we have chosen HRV as our primary endpoint. We hypothesize that the imbalance between the sympathetic and the parasympathetic nervous system caused by chronic stress will result in altered responses to ozone exposure that will be reflected by HRV.

Tipo de estudio

Intervencionista

Inscripción (Actual)

40

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • North Carolina
      • Chapel Hill, North Carolina, Estados Unidos, 27514
        • U.S. EPA Human Studies Facility

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 33 años (Adulto)

Acepta Voluntarios Saludables

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Healthy men and women between 18 and 33 years of age.

    1. 4-point Perceived Stress Symptom score <2 or >6
    2. Physical conditioning allowing intermittent, moderate exercise for two hours.
    3. Ability to complete the exposure exercise regimen without reaching 80% of predicted maximal heart rate.

      Predicted maximal heart rate will be calculated using the equation (described by Tanaka et al. [2001] J. Am. Coll. Cardiol.): [208bpm-((0.7) x (age in years))]

    4. Normal baseline 12-lead resting EKG, or if the automated reading is not normal the EKG must be approved by a study cardiologist.
    5. Normal lung function Forced vital capacity (FVC) ≥ 80% of that predicted for gender, ethnicity, age and height (according to NHANESIII guidelines).

      Forced expiratory volume in one second (FEV1) ≥ 80%of that predicted for gender, ethnicity, age and height.

      FEV1/FVC ratio ≥ 80% of predicted values.

    6. Oxygen saturation ≥ 96% on room air.

Exclusion Criteria:

  • . Individuals with a history of acute or chronic cardiovascular disease, chronic respiratory disease, diabetes, rheumatologic diseases, or immunodeficiency state.

    2. Individuals with a Framingham risk score (Hard Coronary Heart Disease; HCHD; 10-year risk) ≥10.

    3. Individuals with asthma or a history of asthma. 4. Individuals who are allergic to chemical vapors or gases. 5. Females who are pregnant, attempting to become pregnant, or breastfeeding. 6. Individuals that are unwilling or unable to stop taking vitamin C or E, or medications that may impact the results of ozone challenge such at least two weeks prior to the study and for the duration of the study. Medications not specifically mentioned here may be reviewed by the investigators prior to an individual's inclusion in the study.

    7. Individuals who have smoked tobacco during the last five years or those with a history of >5 pack years.

    8. Individuals living with a smoker who smokes inside the house. 9. Individuals with a body mass index (BMI) >35 or <18. Body mass index is calculated by dividing the weight in kilograms by the square of the height in meters.

    10. Individuals with occupational exposures to high levels of vapors, dust, gases, or fumes on an on-going basis.

    11. Individuals with uncontrolled hypertension (≥150 systolic or ≥90 diastolic).

    12. Individuals that do not understand or speak English. 13. Individuals that are unable to perform the exercise required for the study. 14. Individuals that are taking beta blocker medications. 15. Individuals with a history of skin allergies to adhesives used in securing EKG electrodes.

    16. Individuals with unspecified diseases, conditions, or medications that might influence the responses to the exposures, as judged by the medical staff.

    17. Individuals that are unwilling or unable to stop taking over-the-counter pain medications such as aspirin, ibuprofen (Advil, Motrin), naproxen (Aleve), or other non-steroidal anti-inflammatory ("NSAID") medications for 48 hours prior to the exposures and post-exposure visits.

    18. Individuals that are taking systemic steroids or beta-blocker medications. 19. Individuals with a hemoglobin A1c (HbA1c) level > 6.4%.

Temporary Exclusion Criteria

  1. Individuals with active seasonal allergies during the time of participation in the study.
  2. Individuals suffering from acute respiratory illness within four weeks prior to any of the study exposure series.
  3. Individuals that have been exposed to smoke and fumes within 24 hours of any study visit.
  4. Individuals that have consumed alcohol within 24 hours of any study visit.
  5. Individuals that have engaged in strenuous exercise within 24 hours of any study visit.
  6. Individuals that have been exposed to ozone-based home air purifiers within 24 hours of any study visit.
  7. Individuals that have been exposed to unvented household combustion sources (gas stoves, lit fireplaces, oil/kerosene heaters) within 48 hours of any study visit.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Ciencia básica
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación cruzada
  • Enmascaramiento: Doble

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Ozono
La exposición al ozono se llevará a cabo en una cámara de exposición en el Centro de Estudios Humanos de la EPA en el campus de la UNC.
Each subject will be exposed up to 0.3ppm ozone for 2 hours. Subjects will exercise on a bike or treadmill. Each exercise session will consist of a 15 minute exercise interval at a level of up to 25 L/min/m2BSA followed by a 15 minute rest period.
Otros nombres:
  • O3
Comparador falso: Aire limpio
La exposición al aire limpio se llevará a cabo en una cámara de exposición en el Centro de Estudios Humanos de la EPA en el campus de la UNC.
Each subject will be exposed to clean air for 2 hours. Subjects will exercise on a bike or treadmill. Each exercise session will consist of a 15 minute exercise interval at a level of up to 25 L/min/m2BSA followed by a 15 minute rest period.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Cambios en la variabilidad de la frecuencia cardíaca
Periodo de tiempo: Pre exposición a 24 horas después de la exposición
Registro de electrocardiograma de 10 minutos (medido por Holter ECG) en el que el sujeto ha estado descansando durante 20 minutos antes. Recogido en un registrador de ECG de 12 derivaciones Mortara H12+ (Mortara Instrument, Inc., Milwaukee, WI). Los ECG grabados digitalmente se muestrean a 180 Hz.
Pre exposición a 24 horas después de la exposición

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Volumen espirado forzado en el primer segundo (FEV1)
Periodo de tiempo: Pre exposición a 24 horas después de la exposición
El volumen espirado forzado en el primer segundo (FEV1) se determina mediante una espirometría realizada en un espirómetro de sello seco conectado a una computadora.
Pre exposición a 24 horas después de la exposición
Índice de coagulación/factor de coagulación
Periodo de tiempo: Pre exposición a 24 horas después de la exposición
El índice de factores de coagulación/coagulación son los cambios porcentuales medios en una cesta de factores de coagulación/coagulación (dímero D, PA-1, tPA, factor vWillebrand y plasminógeno) en la sangre después de la exposición al ozono frente al aire limpio.
Pre exposición a 24 horas después de la exposición
Índice de marcadores inflamatorios
Periodo de tiempo: Pre exposición a 24 horas después de la exposición
El índice de marcadores inflamatorios es el porcentaje medio de cambios en una cesta de factores relacionados con la inflamación sistémica (IL-6, IL-8, TNF-a, IL-b, CRP) en la sangre después de la exposición al ozono frente al aire limpio.
Pre exposición a 24 horas después de la exposición
Capacidad vital forzada
Periodo de tiempo: Pre exposición a 24 horas después de la exposición
La capacidad vital forzada (FVC) se determina mediante una espirometría realizada en un espirómetro de sello seco conectado a una computadora.
Pre exposición a 24 horas después de la exposición
Cortisol
Periodo de tiempo: Pre exposure to 24hours post exposure
The mean % change of cortisol levels in the blood following exposure to ozone vs. clean air.
Pre exposure to 24hours post exposure
Cognitive function performance
Periodo de tiempo: Pre exposure to 24hours post exposure
Index of cognitive function tests measured using six tests of the Cantab Research Suite (Reaction Time Test (RTI), Attention Switching Task (AST), Spatial Working Memory (SWM), Paired Associate Learning (PAL), Rapid Visual Information Processing (RVP), and Stop Signal Task (SST)) following exposure to ozone vs. clean air.
Pre exposure to 24hours post exposure

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: David Diaz-Sanchez, PhD, U.S. Environmental Protection Agency

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio

1 de julio de 2014

Finalización primaria (Actual)

1 de septiembre de 2016

Finalización del estudio (Actual)

1 de enero de 2017

Fechas de registro del estudio

Enviado por primera vez

30 de julio de 2014

Primero enviado que cumplió con los criterios de control de calidad

30 de julio de 2014

Publicado por primera vez (Estimar)

1 de agosto de 2014

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

26 de julio de 2017

Última actualización enviada que cumplió con los criterios de control de calidad

25 de julio de 2017

Última verificación

1 de julio de 2017

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • # 13-1644

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Ensayos clínicos sobre Clean Air

3
Suscribir